|
|
IN THIS ISSUE
| |
|
In This Issue
Roni Dengler
Genetics in Medicine 2019 21 :1673 - 1673; August 01, 2019; 10.1038/s41436-019-0605-z
|
|
NEWS
| |
|
News
Roni Dengler
Genetics in Medicine 2019 21 :1674 - 1674; August 01, 2019; 10.1038/s41436-019-0604-0
|
|
SYSTEMATIC REVIEW
| |
|
Characteristics and evaluation outcomes of genomics curricula for health professional students: a systematic literature review
Divya Talwar, Wei-Ju Chen, Yu-Lyu Yeh, Margaret Foster, Salah Al-Shagrawi et al.
Genetics in Medicine 2018 21 :1675 - 1682; December 19, 2018; 10.1038/s41436-018-0386-9
|
|
REVIEW ARTICLE
| |
|
Marfan syndrome: improved clinical history results in expanded natural history
Reed E. Pyeritz
Genetics in Medicine 2018 21 :1683 - 1690; December 21, 2018; 10.1038/s41436-018-0399-4
|
|
| |
|
Cancer communication research in the era of genomics and precision medicine: a scoping review
Kimberly A. Kaphingst, Emily Peterson, Jingsong Zhao, Anna Gaysynsky, Ashley Elrick et al.
Genetics in Medicine 2018 21 :1691 - 1698; December 21, 2018; 10.1038/s41436-018-0402-0
|
|
COMMENT
| |
|
A survey assessing adoption of the ACMG-AMP guidelines for interpreting sequence variants and identification of areas for continued improvement
Annie Niehaus, Danielle R. Azzariti, Steven M. Harrison, Marina T. DiStefano, Sarah E. Hemphill et al.
Genetics in Medicine 2019 21 :1699 - 1701; January 23, 2019; 10.1038/s41436-018-0432-7
|
|
| |
|
Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders
Kaylene Ready, Katherine A. Johansen Taber, Natasha Bonhomme & J. Leonard Lichtenfeld
Genetics in Medicine 2019 21 :1702 - 1704; January 28, 2019; 10.1038/s41436-018-0430-9
|
|
| |
|
The illusion of polygenic disease risk prediction
Nicholas J. Wald & Robert Old
Genetics in Medicine 2019 21 :1705 - 1707; January 12, 2019; 10.1038/s41436-018-0418-5
|
|
ARTICLE
| |
|
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
Andrew Lee, Nasim Mavaddat, Amber N. Wilcox, Alex P. Cunningham, Tim Carver et al.
Genetics in Medicine 2019 21 :1708 - 1718; January 15, 2019; 10.1038/s41436-018-0406-9
|
|
| |
|
Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders
Roos van der Donk, Sandra Jansen, Janneke H. M. Schuurs-Hoeijmakers, David A. Koolen, Lia C. M. J. Goltstein et al.
Genetics in Medicine 2018 21 :1719 - 1725; December 20, 2018; 10.1038/s41436-018-0404-y
|
|
| |
|
A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community
Anitra Persaud, Stacy Desine, Katherine Blizinsky & Vence L. Bonham
Genetics in Medicine 2018 21 :1726 - 1734; December 24, 2018; 10.1038/s41436-018-0409-6
|
|
| |
|
Ethnic identity and engagement with genome sequencing research
Erin Turbitt, Megan C. Roberts, Brittany M. Hollister, Katie L. Lewis, Leslie G. Biesecker et al.
Genetics in Medicine 2018 21 :1735 - 1743; December 20, 2018; 10.1038/s41436-018-0410-0
|
|
| |
|
Constructing identities: the implications of DTC ancestry testing for tribal communities
Hina Walajahi, David R. Wilson & Sara Chandros Hull
Genetics in Medicine 2019 21 :1744 - 1750; January 21, 2019; 10.1038/s41436-018-0429-2
|
|
| |
|
Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides
Riccardo Sangermano, Alejandro Garanto, Mubeen Khan, Esmee H. Runhart, Miriam Bauwens et al.
Genetics in Medicine 2019 21 :1751 - 1760; January 15, 2019; 10.1038/s41436-018-0414-9
|
|
| |
|
ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants
Miriam Bauwens, Alejandro Garanto, Riccardo Sangermano, Sarah Naessens, Nicole Weisschuh et al.
Genetics in Medicine 2019 21 :1761 - 1771; January 23, 2019; 10.1038/s41436-018-0420-y
|
|
| |
|
A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblings
Fangning Gu, Anchi Wu, M. Grace Gordon, Lukas Vlahos, Shane Macnamara et al.
Genetics in Medicine 2019 21 :1772 - 1780; January 31, 2019; 10.1038/s41436-019-0434-0
|
|
| |
|
Estimating the burden and economic impact of pediatric genetic disease
Nina Gonzaludo, John W. Belmont, Vladimir G. Gainullin & Ryan J. Taft
Genetics in Medicine 2018 21 :1781 - 1789; December 20, 2018; 10.1038/s41436-018-0398-5
|
|
| |
|
Loss of function of SVBP leads to autosomal recessive intellectual disability, microcephaly, ataxia, and hypotonia
Zafar Iqbal, Hasan Tawamie, Wei Ba, André Reis, Bassam Al Halak et al.
Genetics in Medicine 2019 21 :1790 - 1796; January 04, 2019; 10.1038/s41436-018-0415-8
|
|
| |
|
Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies
Michael D. Fountain, David S. Oleson, Megan E. Rech, Lara Segebrecht, Jill V. Hunter et al.
Genetics in Medicine 2019 21 :1797 - 1807; January 25, 2019; 10.1038/s41436-019-0433-1
|
|
| |
|
Transcription alterations of KCNQ1 associated with imprinted methylation defects in the Beckwith–Wiedemann locus
Federica Maria Valente, Angela Sparago, Andrea Freschi, Katherine Hill-Harfe, Saskia M. Maas et al.
Genetics in Medicine 2019 21 :1808 - 1820; January 12, 2019; 10.1038/s41436-018-0416-7
|
|
| |
|
Phenylalanine and tyrosine measurements across gestation by tandem mass spectrometer on dried blood spot cards from normal pregnant women
Kim L. McBride, Jill Pluciniczak, Timothy Rhyand & Dennis Bartholomew
Genetics in Medicine 2019 21 :1821 - 1826; January 10, 2019; 10.1038/s41436-018-0407-8
|
|
| |
|
Revising the Psychiatric Phenotype of Homocystinuria
Mohamed A. Almuqbil, Susan E. Waisbren, Harvey L. Levy & Jonathan D. Picker
Genetics in Medicine 2019 21 :1827 - 1831; January 15, 2019; 10.1038/s41436-018-0419-4
|
|
| |
|
Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients
Sina Renner, Helke Schüler, Malik Alawi, Verena Kolbe, Meike Rybczynski et al.
Genetics in Medicine 2019 21 :1832 - 1841; January 24, 2019; 10.1038/s41436-019-0435-z
|
|
| |
|
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
D. Max Smith, Kristin W. Weitzel, Amanda R. Elsey, Taimour Langaee, Yan Gong et al.
Genetics in Medicine 2019 21 :1842 - 1850; January 23, 2019; 10.1038/s41436-018-0431-8
|
|
SPECIAL ARTICLE
| |
|
Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
Nicola Longo, David Dimmock, Harvey Levy, Krista Viau, Heather Bausell et al.
Genetics in Medicine 2018 21 :1851 - 1867; December 14, 2018; 10.1038/s41436-018-0403-z
|
|
BRIEF COMMUNICATION
| |
|
Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition
Alisa Olkinuora, Taina T. Nieminen, Emma Mårtensson, Anna Rohlin, Ari Ristimäki et al.
Genetics in Medicine 2018 21 :1868 - 1873; December 21, 2018; 10.1038/s41436-018-0405-x
|
|
| |
|
Current conditions in medical genetics practice
Deborah R. Maiese, Alisha Keehn, Megan Lyon, David Flannery & Michael Watson
Genetics in Medicine 2019 21 :1874 - 1877; January 28, 2019; 10.1038/s41436-018-0417-6
|
|
CORRESPONDENCE
| |
|
Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer?
D. G. Evans, E. R. Woodward, F. Lalloo, P. Møller, J. Sampson et al.
Genetics in Medicine 2018 21 :1878 - 1879; December 14, 2018; 10.1038/s41436-018-0401-1
|
|
| |
|
Response to Evans et al.
Maegan E. Roberts, Nur Zeinomar, Benjamin D. Solomon, Mary Beth Terry & Wendy K. Chung
Genetics in Medicine 2018 21 :1880 - 1881; December 19, 2018; 10.1038/s41436-018-0400-2
|
|
| |
|
45,X mosaicism in a population-based biobank: implications for Turner syndrome
Siddharth K. Prakash, Melissa L. Crenshaw, Philippe F. Backeljauw, Michael Silberbach, Cindy Scurlock et al.
Genetics in Medicine 2018 21 :1882 - 1883; December 21, 2018; 10.1038/s41436-018-0411-z
|
|
| |
|
Response to Prakash et al.
Marcus A. Tuke, Katherine S. Ruth, Andrew R. Wood, Robin N. Beaumont, Jessica Tyrrell et al.
Genetics in Medicine 2018 21 :1884 - 1885; December 21, 2018; 10.1038/s41436-018-0412-y
|
|
| |
|
Considerations for pharmacogenomic testing in a health system
Roseann S. Gammal, Kelly E. Caudle, Teri E. Klein & Mary V. Relling
Genetics in Medicine 2019 21 :1886 - 1887; January 09, 2019; 10.1038/s41436-018-0421-x
|
|
| |
|
Response to Gammal et al.
Jason L. Vassy, Annjanette Stone, John T. Callaghan, Margaret Mendes, Laurence J. Meyer et al.
Genetics in Medicine 2019 21 :1888 - 1889; January 12, 2019; 10.1038/s41436-018-0422-9
|
|
| |
|
Fabry disease cardiac variant IVS4+919 G>A is associated with multiple cardiac gene variants in patients with severe cardiomyopathy and fatal arrhythmia
Jyh-Ming Jimmy Juang, Chia-Tung Shun, Yih-Sharng Chen, Wuh-Liang Hwu, Ni-Chung Lee et al.
Genetics in Medicine 2019 21 :1890 - 1891; January 21, 2019; 10.1038/s41436-019-0436-y
|
|
| |
|
Response to Juang et al.
Chia-Lin Hsu, Ivan L. Dzhagalov & Dau-Ming Niu
Genetics in Medicine 2019 21 :1892 - 1893; January 22, 2019; 10.1038/s41436-019-0437-x
|
|
CORRECTION
| |
|
Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
Amalia M. Issa, Adrian Thorogood, Yann Joly & Bartha M. Knoppers
Genetics in Medicine 2018 21 :1894 - 1900; September 04, 2018; 10.1038/s41436-018-0264-5
|
|
| |
|
Correction: Arterial tortuosity syndrome: 40 new families and literature review
Aude Beyens, Juliette Albuisson, Annekatrien Boel, Mazen Al-Essa, Waheed Al-Manea et al.
Genetics in Medicine 2018 21 :1894 - 1895; September 10, 2018; 10.1038/s41436-018-0035-3
|
|
| |
|
Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
Julie W. Rutten, Bastian J. Van Eijsden, Marco Duering, Eric Jouvent, Christian Opherk et al.
Genetics in Medicine 2018 21 :1895 - 1895; September 20, 2018; 10.1038/s41436-018-0306-z
|
|
| |
|
Correction: The landscape of epilepsy-related GATOR1 variants
Sara Baldassari, Fabienne Picard, Nienke E. Verbeek, Marjan van Kempen, Eva H. Brilstra et al.
Genetics in Medicine 2018 21 :1896 - 1896; September 27, 2018; 10.1038/s41436-018-0325-9
|
|
| |
|
Correction: IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients
Cyril Mignot, Aoife C. McMahon, Claire Bar, Philippe M. Campeau, Claire Davidson et al.
Genetics in Medicine 2018 21 :1897 - 1898; October 02, 2018; 10.1038/s41436-018-0327-7
|
|
| |
|
Correction: Mapping the genomic landscape of inherited retinal disease genes prioritizes genes prone to coding and noncoding copy-number variations
Kristof Van Schil, Sarah Naessens, Stijn Van de Sompele, Marjolein Carron, Alexander Aslanidis et al.
Genetics in Medicine 2018 21 :1998 - 1998; October 08, 2018; 10.1038/s41436-018-0305-0
|
|
| |
|
Correction: TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants
Jennifer N. Dines, Katie Golden-Grant, Amy LaCroix, Alison M. Muir, Dianne Laboy Cintrón et al.
Genetics in Medicine 2018 21 :1899 - 1899; October 15, 2018; 10.1038/s41436-018-0336-6
|
|
| |
|
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
Hiroki Maruyama, Kaori Miyata, Mariko Mikame, Atsumi Taguchi, Chu Guili et al.
Genetics in Medicine 2018 21 :1900 - 1900; September 12, 2018; 10.1038/s41436-018-0258-3
|
|
PODCAST
| |
|
|
Podcast FREE
|
|
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου